Device-detected subclinical atrial tachyarrhythmias: Definition, implications and management - An European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

TY - JOUR

T1 - Device-detected subclinical atrial tachyarrhythmias

T2 - Definition, implications and management - An European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

AU - Gorenek, Bulent

AU - Bax, Jeroen

AU - Boriani, Giuseppe

AU - Chen, Shih Ann

AU - Dagres, Nikolaos

AU - Glotzer, Taya V.

AU - Healey, Jeff S.

AU - Israel, Carsten W.

AU - Kudaiberdieva, Gulmira

AU - Levin, Lars Åke

AU - Lip, Gregory Y.H.

AU - Martin, David

AU - Okumura, Ken

AU - Svendsen, Jesper H.

AU - Tse, Hung Fat

AU - Botto, Giovanni L.

AU - Linde, Cecilia

AU - Kutyifa, Valentina

AU - Bernat, Robert

AU - Scherr, Daniel

AU - Lau, Chu Pak

AU - Iturralde, Pedro

AU - Morin, Daniel P.

AU - Savelieva, Irina

N1 - Publisher Copyright: © 2017 The Author.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Among atrial tachyarrhythmias (AT), atrial fibrillation (AF) is the most common sustained arrhythmia. Many patients with AT have no symptoms during brief or even extended periods of the arrhythmia, making detection in patients at risk for stroke challenging. Subclinical atrial tachyarrhythmia and asymptomatic or silent atrial tachyarrhythmia often precede the development of clinical AF. Clinical AF and subclinical atrial fibrillation (SCAF) are associated with an increased risk of thromboembolism. Indeed, in many cases, SCAF is discovered only after complications such as ischaemic stroke or congestive heart failure have occurred.

AB - Among atrial tachyarrhythmias (AT), atrial fibrillation (AF) is the most common sustained arrhythmia. Many patients with AT have no symptoms during brief or even extended periods of the arrhythmia, making detection in patients at risk for stroke challenging. Subclinical atrial tachyarrhythmia and asymptomatic or silent atrial tachyarrhythmia often precede the development of clinical AF. Clinical AF and subclinical atrial fibrillation (SCAF) are associated with an increased risk of thromboembolism. Indeed, in many cases, SCAF is discovered only after complications such as ischaemic stroke or congestive heart failure have occurred.

UR - https://www.scopus.com/pages/publications/85028987368

U2 - 10.1093/europace/eux163

DO - 10.1093/europace/eux163

M3 - Review article

C2 - 28934408

SN - 1099-5129

VL - 19

SP - 1556

EP - 1578

JO - Europace

JF - Europace

IS - 9

ER -